ATLANTA, Oct. 30 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a biomaterials, medical device and tissue processing company, announced today that Scott B. Capps has been named vice president, clinical research, effective October 29, 2007. Mr. Capps has served as vice president and general manager of CryoLife Europa, Ltd., based in the U.K., since February 2005.
Mr. Capps joined CryoLife in 1995 and has held several positions with the Company including project director for heart valves, director of clinical research and director of European clinical affairs. He is a graduate of the Georgia Institute of Technology and holds a Master's degree in bioengineering from Clemson University.
In a related move, David N. Hollinworth, Ph.D., has joined the company as vice president and general manager of CryoLife Europa, Ltd., effective October 29, 2007. Previously, Dr. Hollinworth held various management positions including chief executive officer of Chameleon Biosurfaces, European cardiology marketing manager of Siemens Medical and European market development manager in cardiology at Medtronic. Dr. Hollinworth holds a Ph.D. in biochemistry from The University of Bristol and an M.B.A. from the London Business School.
"Scott did a terrific job for CryoLife Europa, and we are very excited
about tapping into the expertise he gained while there. His experiences
with CryoLife, both in Europe and stateside, make him well qualified to
lead our clinical operations here," said Steven G. Anderson, president and
CEO of CryoLife, Inc. "I am also very pleased to welcome Dr. Hollinworth as
general manager of CryoLife Europa. His extensive background in the
marketing of new technologies and products will be of great ass
'/>"/>
| SOURCE CryoLife, Inc. Copyright©2007 PR Newswire. All rights reserved |